Bruker Corporation (BRKR) News
Filter BRKR News Items
BRKR News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
BRKR News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest BRKR News From Around the Web
Below are the latest news stories about BRUKER CORP that investors may wish to consider to help them evaluate BRKR as an investment opportunity.
Bruker Launches Infrared Imaging Microscope for Pharma and Life Science ResearchBILLERICA, Mass., January 08, 2025--Bruker Corporation (Nasdaq: BRKR) today announced the launch of the LUMOS™ II ILIM, a quantum cascade laser (QCL) based infrared imaging microscope. The new LUMOS II ILIM redefines performance standards, enabling pharma and life science researchers to capture ultrafast IR images of expansive areas with enhanced spatial resolution. |
Bruker Corporation to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceBILLERICA, Mass., January 07, 2025--Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 43rd annual J.P. Morgan Healthcare Conference in San Francisco. Frank Laukien, Chairman, President & CEO, Mark Munch, Executive Vice President & President of Bruker Nano Group, and Gerald Herman, Executive Vice President & CFO will present on behalf of the Company on Monday, January 13th, 2025 at 3:45 PM Pacific Standard Time. |
Is Bruker Corporation (BRKR) Among the Best Nanotechnology Stocks to Buy According to Hedge Funds?We recently published a list of the 12 Best Nanotechnology Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Bruker Corporation (NASDAQ:BRKR) stands against the other best nanotechnology stocks to buy. Nanotechnology, a groundbreaking concept introduced by Nobel Prize-winning physicist Richard Feynman in 1959 during […] |
Bruker seeks to pause injunction of GeoMx in the US after court rulingA US court previously found that NanoString – acquired by Bruker earlier this year – infringed on patented technology developed by 10x Genomics. |
Investors in Bruker (NASDAQ:BRKR) have unfortunately lost 27% over the last three yearsAs an investor its worth striving to ensure your overall portfolio beats the market average. But the risk of stock... |
Bruker ‘respectfully disagrees’ with District Court, to seek stay of injunctionBruker (BRKR) earlier today commented on the ruling of the U.S. District Court for the District of Delaware in the case involving GeoMx Digital Spatial Profiler products sold by its NanoString (NSTG) business. “Yesterday, the Court issued its ruling on the post-trial motions that followed the November 2023 jury verdict in the patent infringement case between NanoString and 10x Genomics. In its ruling, the District Court upheld the jury’s damages award of approximately $31.6 million plus interest |
Update: 10x Genomics Secures Court Injunction Against Bruker's Sale of GeoMx Products in US(Updates with Bruker's statement in the sixth and seventh paragraphs.) 10x Genomics (TXG) said la |
Bruker Comments on Delaware District Court’s Post-Trial Ruling in Case Involving GeoMx Digital Spatial Profiler ProductsBILLERICA, Mass., December 24, 2024--Bruker Corporation (Nasdaq: BRKR) today commented on the ruling of the U.S. District Court for the District of Delaware in the case involving GeoMx® Digital Spatial Profiler products sold by its NanoString business. Yesterday, the Court issued its ruling on the post-trial motions that followed the November 2023 jury verdict in the patent infringement case between NanoString and 10x Genomics. In its ruling, the District Court upheld the jury’s damages award of |
10x Genomics Secures Court Injunction Against Bruker's Sale of GeoMx Products in US10x Genomics (TXG) said late Monday a US court issued a permanent injunction against the sale of Geo |
U.S. District Court Awards 10x Genomics Permanent Injunction in Patent Infringement Lawsuit Against Bruker Corporation's GeoMx Products10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today it had secured a permanent injunction in the U.S. District Court for the District of Delaware against the GeoMx products sold by Bruker Corporation (Nasdaq: BRKR), which acquired the product line from NanoString Technologies. To minimize the risk of disruption to ongoing research, 10x Genomics requested a carve-out for GeoMx users who installed an instrument prior to the trial in November 2023. |